Gilead Sciences
  • GILD

  • $91.94

  • -1.55%
  • $93.50

  • $94.22

  • $92.03

Ticker Appearances

Daily Technical Strategy
Thu, August 29, 2024 | 6:30PM ET

This report is accessible to
FSI Pro, FSI Macro memberships.

You've hit your free report limit (2/2).

Join today to keep reading and take advantage of the
biggest savings of the year during our:

Already have an account? Sign In

Visitor:7584e7-ae0e4f-6a2286-e059cf-305f08

Daily Technical Strategy
Wed, August 28, 2024 | 6:50PM ET

This report is accessible to
FSI Pro, FSI Macro memberships.

You've hit your free report limit (2/2).

Join today to keep reading and take advantage of the
biggest savings of the year during our:

Already have an account? Sign In

Visitor:7584e7-ae0e4f-6a2286-e059cf-305f08

Wed, August 28, 2024 | 11:32AM ET

⚡ FlashInsights

Wed, August 28, 2024 | 11:32AM ET
I'll take a brief break from discussing NVDA to mention that Equal-weighted Healthcare is on the verge of breaking back out to new all-time highs, something that XLV accomplished last month. Indeed, the top 5 performers today within SPX are all Healthcare related: PODD -0.79% , BIO 0.97% , BMY 0.31% , GILD -1.55% , and VRTX 0.47% . This sector has grown in appeal over the last couple months after a lackluster 1H 2024 and we've begun to see some very attractive basing patterns in XBI, IBB along with XHS and IHI that make this sector one to expect continued outperformance at a time when many remain solely focused on Technology. Given that Healthcare is the 2nd highest weighted Sector within SPX behind Technology, seeing strength in this sector is very constructive for the broader market and provides a "perhaps unnoticeable" tailwind. Ok, sorry for the diversion. Back to NVDA. (2 charts shown the first is MarketSurge Chart of Invesco's Equal-weighted Healthcare ETF (RYH) since early 2024 and the second is the same ETF, shown breaking out of its base since 2021)

Daily Technical Strategy
Mon, May 13, 2024 | 6:37PM ET

AAPL behavior gives confidence ahead of this week’s CPI print

EQUITIES HAVE EXTENDED GAINS AND HAVE NOW COME WITHIN STRIKING DISTANCE OF LATE MARCH PEAKS.   SPX HAS NEARLY RECAPTURED ALL OF THE PERIOD OF WEAKNESS...

This report is accessible to
FSI Pro, FSI Macro memberships.

You've hit your free report limit (2/2).

Join today to keep reading and take advantage of the
biggest savings of the year during our:

Already have an account? Sign In

Visitor:7584e7-ae0e4f-6a2286-e059cf-305f08

Daily Technical Strategy
Thu, August 10, 2023 | 8:02PM ET

Technical reasons why an Equity low is near

Schedule Update: I will be traveling on Friday (8/11) and there will be no Daily Technical Report nor Technical Video published. Daily technical strategy will...

This report is accessible to
FSI Pro, FSI Macro memberships.

You've hit your free report limit (2/2).

Join today to keep reading and take advantage of the
biggest savings of the year during our:

Already have an account? Sign In

Visitor:7584e7-ae0e4f-6a2286-e059cf-305f08

Daily Technical Strategy
Mon, November 14, 2022 | 6:27PM ET

Biotech breakout worth following as Healthcare gets stronger

The near-term picture still looks positive for US benchmark indices and while momentum has reached intra-day overbought levels, this doesn’t imply a selloff has to...

This report is accessible to
FSI Pro, FSI Macro memberships.

You've hit your free report limit (2/2).

Join today to keep reading and take advantage of the
biggest savings of the year during our:

Already have an account? Sign In

Visitor:7584e7-ae0e4f-6a2286-e059cf-305f08

Events

Trending tickers in our research